ANDA 85597, held by Watson Laboratories. Methylprednisolone Acetate.
As of Nov 21, 2026, ANDA 85597 (Methylprednisolone Acetate), held by Watson Laboratories, was first approved by FDA on Mar 14, 1979, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 14, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylprednisolone Acetate20MG/ML · injectable;injection | Methylprednisolone Acetate | Discontinued |
| Feb 19, 1999 | Supplement 37Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 35Manufacturing | Approved | None posted |
| Nov 18, 1998 | Supplement 34Manufacturing | Approved | None posted |
| Apr 10, 1997 | Supplement 33Manufacturing | Approved | None posted |
| Jun 13, 1996 | Supplement 31Labeling | Approved | None posted |
| Jun 13, 1996 | Supplement 30Manufacturing | Approved | None posted |
| Jun 13, 1996 | Supplement 29Manufacturing | Approved | None posted |
| Mar 15, 1994 | Supplement 28Labeling | Approved | None posted |
| Dec 1, 1992 | Supplement 27Labeling | Approved | None posted |
| Mar 18, 1991 | Supplement 26Labeling | Approved | None posted |
| Nov 21, 1989 | Supplement 25Labeling | Approved | None posted |
| Feb 16, 1989 | Supplement 21Labeling | Approved | None posted |
| Dec 28, 1988 | Supplement 23Labeling | Approved | None posted |
| Dec 28, 1988 | Supplement 22Manufacturing | Approved | None posted |
| Nov 29, 1988 | Supplement 24Bioequivalence | Approved | None posted |
| Jun 16, 1986 | Supplement 18Manufacturing | Approved | None posted |
| Nov 20, 1984 | Supplement 17Manufacturing | Approved | None posted |
| Nov 20, 1984 | Supplement 15Manufacturing | Approved | None posted |
| Feb 25, 1983 | Supplement 14Manufacturing | Approved | None posted |
| Mar 14, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters